| Study to Estimate the Disease Burden of Acute Rotavirus Gastroenteritis in Children < 5 Years in United Arab Emirates (NCT01201252) | GlaxoSmithKline | 2009-07-01 |
| Predictive Ability of Therapeutic Risk Factors in Pediatric and Adult Asthma Patients (NCT01346852) | GlaxoSmithKline | 2009-07-01 |
| A Repeat Dose Positron Emission Tomography Study With GSK1144814 (NCT01209039) | GlaxoSmithKline | 2009-07-01 |
| Treximet ™ Pharmacy Budget Impact Model Database Validation Study (NCT01332500) | GlaxoSmithKline | 2009-07-01 |
| Outcomes for Medicare Asthma Patients Taking Fluticasone Propionate/Salmeterol Xinafoate Combination Versus Inhaled Corticosteroids or Other Combination Therapy (NCT01347060) | GlaxoSmithKline | 2009-07-01 |
| GSK2190915 Moderate to Severe Asthma Study (NCT00850642) | GlaxoSmithKline | 2009-06-26 |
| Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants (NCT00871338) | GlaxoSmithKline | 2009-06-24 |
| Vaccination With GSK 1024850A in Children Primed With GSK 1024850A & Boosted With Pneumovax 23™ (NCT00907777) | GlaxoSmithKline | 2009-06-23 |
| A Phase I, Open-Label, First-Time-In-Human Study of the Oral AKT Inhibitor GSK2141795 (NCT00920257) | GlaxoSmithKline | 2009-06-16 |
| A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults (NCT00920374) | GlaxoSmithKline | 2009-06-16 |
| Study to Test GSK256073 in Patients With Dyslipidemia (NCT00903617) | GlaxoSmithKline | 2009-06-15 |
| [11C]Carfentanil PET Study of GSK1521498 (NCT00976066) | GlaxoSmithKline | 2009-06-15 |
| Booster Vaccination Study With a Pneumococcal Vaccine in Children Primed With the Same Vaccine (NCT00911144) | GlaxoSmithKline | 2009-06-11 |
| A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics (NCT01119846) | GlaxoSmithKline | 2009-06-05 |
| Cantharidin-induced Skin Blister for Testing Anti-inflammatory Effects of Macrolides (NCT01026064) | GlaxoSmithKline | 2009-06-04 |
| A Phase I Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2118436 in Subjects With Solid Tumors (NCT00880321) | GlaxoSmithKline | 2009-06-04 |
| Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age (NCT00861744) | GlaxoSmithKline | 2009-06-03 |
| Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds (NCT00892775) | GlaxoSmithKline | 2009-06-03 |
| Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study (NCT00929526) | GlaxoSmithKline | 2009-06-01 |
| Use of Fluticasone Propionate/Salmeterol Combination Post Emergency Department Visit (NCT01332357) | GlaxoSmithKline | 2009-06-01 |
| Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' IPV Vaccine (PoliorixTM) in Toddlers (NCT00920439) | GlaxoSmithKline | 2009-06-01 |
| 723/726 Proof of Concept Study in Allergen Challenge Chamber in Hannover (NCT00972504) | GlaxoSmithKline | 2009-06-01 |
| At What Time Therapeutic Plasma Concentrations of Paracetamol Are Achieved in Two Marketed Formulations (NCT01551836) | GlaxoSmithKline | 2009-06-01 |
| Comparison of Asthma-related Outcomes and Costs in Pediatric Subjects That Received Fluticasone Propionate, Budesonide or Montelukast in a Large Managed Care Population (NCT01328964) | GlaxoSmithKline | 2009-06-01 |
| Meta-analysis of Efficacy of Topotecan (NCT01160185) | GlaxoSmithKline | 2009-06-01 |
| Indirect Comparison Topotecan Cervical Carcinoma (NCT01345279) | GlaxoSmithKline | 2009-06-01 |
| Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs (NCT00920088) | GlaxoSmithKline | 2009-06-01 |
| QTc Study of Rosi XR in Healthy Volunteers (NCT00884533) | GlaxoSmithKline | 2009-06-01 |
| The Effect of Single Doses of the Motilin Receptor Agonist GSK962040 in Type I Diabetic Patients With Gastroparesis (NCT00861809) | GlaxoSmithKline | 2009-06-01 |
| Study to Identify and Characterize the Bacteria Causing Acute Otitis Media Episodes in Young Children in Saudi Arabia (NCT01204385) | GlaxoSmithKline | 2009-06-01 |
| Outcomes in Patients Taking Fluticasone Propionate/Salmeterol Combination or Other Inhaled Corticosteroids (NCT01332344) | GlaxoSmithKline | 2009-06-01 |
| A Study of Safety and Clinical Activity of Immunotherapy Plus Chemotherapy in Metastatic Melanoma Patients (NCT00849875) | GlaxoSmithKline | 2009-05-26 |
| Effectiveness of Flu Vaccination and Burden of Illness Among Community-dwelling Elderly With Influenza Like Illness in Brazil (NCT01171157) | GlaxoSmithKline | 2009-05-26 |
| Study of GSK2132231A Antigen-Specific Cancer Immunotherapeutic in Patients With Inoperable Metastatic Cutaneous Melanoma (NCT00896480) | GlaxoSmithKline | 2009-05-19 |
| Evaluation of a Booster Dose of Pneumococcal Vaccine Formulations in Young Adults (NCT00896064) | GlaxoSmithKline | 2009-05-18 |
| A Study to Evaluate the Effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and in Combination on Resting Motor Threshold in Healthy Subjects (NCT00907985) | GlaxoSmithKline | 2009-05-15 |
| Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib Vaccines (NCT00891176) | GlaxoSmithKline | 2009-05-14 |
| Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS) (NCT00903422) | GlaxoSmithKline | 2009-05-14 |
| First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis (NCT00875446) | GlaxoSmithKline | 2009-05-13 |
| Mepolizumab in Nasal Polyposis (NCT01362244) | GlaxoSmithKline | 2009-05-12 |
| A Repeat Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Subjects (NCT00896558) | GlaxoSmithKline | 2009-05-11 |
| Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects. (NCT00877877) | GlaxoSmithKline | 2009-05-07 |
| Breast Cancer With Over-expression of erbB2-BRAINSTORM (NCT01064349) | GlaxoSmithKline | 2009-05-06 |
| Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease (NCT00861380) | GlaxoSmithKline | 2009-05-04 |
| Fracture Risk With Thiazolidinediones (NCT01055223) | GlaxoSmithKline | 2009-05-01 |
| Birth Defects Associated With Exposure to Lamotrigine in Pregnancy (EUROCAT) (NCT01055327) | GlaxoSmithKline | 2009-05-01 |
| CV Events in Emetogenic Chemotherapy (NCT01366599) | GlaxoSmithKline | 2009-05-01 |
| Study to Identify and Characterize Bacteria Causing Acute Otitis Media in South African Children (NCT01031082) | GlaxoSmithKline | 2009-05-01 |
| Phase II Study of Ofatumumab Plus Ifosfamide, Carboplatin, Etoposide (ICE) or Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Regimen in Relapsed/ Refractory Diffuse Large B Cell Lymphoma (DLBCL) (NCT00823719) | GlaxoSmithKline | 2009-05-01 |
| Efficacy and Safety Study of Nicotine Mint Lozenge (2mg and 4mg) in Smoking Cessation (NCT00985985) | GlaxoSmithKline | 2009-05-01 |
| Vestipitant 28-day Tolerance Study (NCT00992160) | GlaxoSmithKline | 2009-05-01 |
| Safety Study of GSK Biologicals' HPV Vaccine (GSK-580299) in Healthy Female Subjects. (NCT00811798) | GlaxoSmithKline | 2009-05-01 |
| Special Drug Use Investigation for AMERGE® Tablet (Long-term) (NCT01332383) | GlaxoSmithKline | 2009-05-01 |
| Acceptability of Hepatitis B Vaccination in General Population (NCT01782794) | GlaxoSmithKline | 2009-05-01 |
| Effects of GSK598809 on Brain Activation in Abstinent Alcoholics (NCT00908206) | GlaxoSmithKline | 2009-05-01 |
| Evaluation of Antibody Persistence & Immune Memory in Subjects Vaccinated During Adolescence With Twinrix™ (NCT00875485) | GlaxoSmithKline | 2009-05-01 |
| Thiazolidinedione Intervention With Vitamin D Evaluation (NCT00879970) | GlaxoSmithKline | 2009-05-01 |
| Establishing Predictors of Enlarged Prostate Treatment Adherence: Linking Symptom Improvement to Adherence (NCT01390870) | GlaxoSmithKline | 2009-05-01 |
| Relative Bioavailability Study in Healthy Subjects (NCT00924911) | GlaxoSmithKline | 2009-04-27 |
| Safety and Efficacy Study in Patients With Major Depressive Disorder (NCT00896363) | GlaxoSmithKline | 2009-04-23 |
| GSK2190915A - Bioavailability Study (NCT02224521) | GlaxoSmithKline | 2009-04-20 |
| Safety Study of GSK Biologicals' Rotavirus Vaccine (Rotarix®) Administered to Children Aged <1 Year in the United States (NCT00875641) | GlaxoSmithKline | 2009-04-20 |
| ARI103094-Follow-Up Study for REDUCE Study Subjects (NCT00883909) | GlaxoSmithKline | 2009-04-09 |
| Clinical Study to Assess the Effects of SRT2104 and Prednisolone on Biomarkers in Blood in Healthy Volunteers (NCT00920660) | GlaxoSmithKline | 2009-04-06 |
| Bioequivalence Study of Cephalexin Tablets 1g (NCT01767584) | GlaxoSmithKline | 2009-04-06 |
| An Open Label Positron Emission Tomography Study in Healthy Male Subjects to Investigate Brain DAT and SERT Occupancy,Pharmacokinetics and Safety of Single Oral Doses of GSK1360707, Using 11C- PE2I and 11C-DASB as PET Ligands (NCT01153802) | GlaxoSmithKline | 2009-04-03 |
| Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children. (NCT00871000) | GlaxoSmithKline | 2009-04-01 |
| Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Brazil, Taiwan or Thailand (NCT00849381) | GlaxoSmithKline | 2009-04-01 |
| Controlled-release Paroxetine in Major Depressive Disorder (Double-blind, Placebo-controlled Study) (NCT00866294) | GlaxoSmithKline | 2009-04-01 |
| Lapatinib in Combination With Vinorelbine (NCT01128543) | GlaxoSmithKline | 2009-04-01 |
| GSK1349572 Drug Interaction Study With Atazanavir/Ritonavir and Atazanavir (NCT00883935) | GlaxoSmithKline | 2009-04-01 |
| Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age. (NCT00871741) | GlaxoSmithKline | 2009-04-01 |
| Special Drug Use Investigation for LAMICTAL® (Long Term) (NCT01863602) | GlaxoSmithKline | 2009-04-01 |
| Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) Tablet (NCT01376193) | GlaxoSmithKline | 2009-04-01 |
| Human Papillomavirus (HPV) Type Distribution in Adult Women Diagnosed With Invasive Cervical Cancer in New Zealand (NCT01328028) | GlaxoSmithKline | 2009-04-01 |
| Use of Beta-blockers and Risk of New Onset Diabetes (NCT01587638) | GlaxoSmithKline | 2009-04-01 |
| Immunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 Years (NCT00871117) | GlaxoSmithKline | 2009-03-31 |
| Efficacy of GSK Biologicals' Candidate Malaria Vaccine 257049 Against Malaria Disease in Infants and Children in Africa (NCT00866619) | GlaxoSmithKline | 2009-03-27 |
| Tafenoquine/Chloroquine DDI Study (NCT00871156) | GlaxoSmithKline | 2009-03-24 |
| Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of SRT2104 Administered to Normal Healthy Male Volunteers (NCT00933062) | GlaxoSmithKline | 2009-03-23 |
| VEG111485: A QTc Study of Pazopanib (NCT00861029) | GlaxoSmithKline | 2009-03-19 |
| Repeat Dose Safety Study for Compound to Treat Anemia (NCT00840320) | GlaxoSmithKline | 2009-03-13 |
| Study to Assess the Safety of a New GSK Biologicals' GSK2231395A Candidate Vaccine (NCT00849069) | GlaxoSmithKline | 2009-03-12 |
| A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder (NCT00880048) | GlaxoSmithKline | 2009-03-11 |
| A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast Cancer (NCT00849329) | GlaxoSmithKline | 2009-03-10 |
| Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of Age (NCT00814710) | GlaxoSmithKline | 2009-03-07 |
| A Study to Examine the Effects of Low and High-fat Meals on Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer Patients (NCT00821054) | GlaxoSmithKline | 2009-03-06 |
| A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder (NCT00880399) | GlaxoSmithKline | 2009-03-01 |
| Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's Disease (NCT00823836) | GlaxoSmithKline | 2009-03-01 |
| Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford Database Assessment (NCT01386983) | GlaxoSmithKline | 2009-03-01 |
| A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT00857766) | GlaxoSmithKline | 2009-03-01 |
| Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study) (NCT00812812) | GlaxoSmithKline | 2009-03-01 |
| A Phase II Trial of Ofatumumab in Subjects With Waldenstrom's Macroglobulinemia (NCT00811733) | GlaxoSmithKline | 2009-03-01 |
| CR9112792, a Follow-up of Study CR9108963 (NCT00891553) | GlaxoSmithKline | 2009-03-01 |
| Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A (NCT00839254) | GlaxoSmithKline | 2009-02-18 |
| Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age. (NCT00829010) | GlaxoSmithKline | 2009-02-17 |
| Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine. (NCT00835237) | GlaxoSmithKline | 2009-02-17 |
| A Study to Evaluate the Effect of GW870086X on Allergen Challenge in Mild Asthmatics (NCT00857857) | GlaxoSmithKline | 2009-02-16 |
| Safety of the HIV Vaccine 732462 in HIV Infected Subjects Aged 18 to 55 Years Old (NCT00814762) | GlaxoSmithKline | 2009-02-03 |
| Liver Function Test (LFT) Elevations in Cancer Patients and Users of Tyrosine Kinase Inhibitor (TKI) Drugs (NCT01098500) | GlaxoSmithKline | 2009-02-01 |